ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2021 and some content may be unavailable. To unlock all content for 2021, please visit the archives.

Abstract: PO1053

Using the Seraph® 100 Microbind® Affinity Blood Filter Under Slow Flow Conditions Through a Normal Central Line

Session Information

Category: Dialysis

  • 703 Dialysis: Vascular Access

Authors

  • Seffer, Malin-Theres, Academic Teaching Hospital Braunschweig, Braunschweig, Germany
  • Schmidt, Julius, Medizinische Hochschule Hannover, Hannover, Niedersachsen, Germany
  • Kielstein, Jan T., Academic Teaching Hospital Braunschweig, Braunschweig, Germany

Group or Team Name

  • Kielstein Lab
Background

The Seraph® 100 Microbind® Affinity blood filter has been in use since 2019 for the treatment of difficult to treat blood stream infections.and since 2020 for the treatment of critically ill COVID-19 patients. It is operated under blood flow rates of 100 – 350 mL/min, which requires a large bore central line a dialysis catheter. The aim of our study was to evaluate to evaluate the usability of the Seraph® 100 under slow flow conditions through a normal central line (in clinical practice).

Methods

A standard hemoperfusion blood tubing system as well as the Seraph® 100 (Exthera Medical, CA, USA) was used. Vascular access was a 20 cm trillumen central venous line (2 x 18 G and 1 x 16 G) that was inserted into a reservoir. The Multifiltrate (Fresenius Medical Care) was used to pump normal saline (n=5) or human plasma (n=5) through the Seraph® 100. Pressures were recored at any given flows (Qb).
In two patients connected to a five lumen 20 cm catheter (Certofix Safety Quinto S1220, B. Braun, Melsungen, Germany - 1 x 12 G, 1 x 16 G, 3 x 18 G) blood flow as well as arterial and venous pressure were recorded through the 24 h treatment.

Results

Using saline or human plasma the Seraph® 100 Microbind®Affinity Blood Filter can be operatied at blood flow rates of up to 100 mL/min even through a 16 & 18 G lumen at tolerable arterial and venous pressures. In men using either the 12 G or the 16 G lumen as "arterial line" blood a blood flow rate of 50 mL/mon could be onbtained for 24 hours without problems.

Conclusion

The Seraph® 100 Microbind®Affinity Blood Filter can be operated at blood flow rates of 50 mL/min even through 16 & 18 G catheters.

"Arterial" and "venous" pressures depending on the flow (Qb) during hemoperfusion with the Seraph® 100 Microbind®Affinity Blood Filter.